SPPI Spectrum Pharmaceuticals Inc

Price (delayed)

$3.245

Market cap

$524.13M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.17

Enterprise value

$454.61M

Highlights
The company's EPS rose by 9% QoQ and by 2.5% YoY
The quick ratio rose by 2% QoQ
SPPI's net income is down by 16% YoY but it is up by 3% QoQ
Spectrum Pharmaceuticals's equity has decreased by 20% YoY and by 9% QoQ

Key stats

What are the main financial stats of SPPI
Market
Shares outstanding
161.52M
Market cap
$524.13M
Enterprise value
$454.61M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.07
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$156.06M
EBITDA
-$154.31M
Free cash flow
-$126.99M
Per share
EPS
-$1.17
Free cash flow per share
-$0.87
Book value per share
$0.8
Revenue per share
$0
TBVPS
$1.23
Balance sheet
Total assets
$179.01M
Total liabilities
$56.57M
Debt
$0
Equity
$122.44M
Working capital
$121.83M
Liquidity
Debt to equity
0
Current ratio
3.57
Quick ratio
3.5
Net debt/EBITDA
0.45
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-77.2%
Return on equity
-112.3%
Return on invested capital
-199.4%
Return on capital employed
-118.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SPPI stock price

How has the Spectrum Pharmaceuticals stock price performed over time
Intraday
3.67%
1 week
0.78%
1 month
-10.85%
1 year
-9.86%
YTD
-4.84%
QTD
-13.47%

Financial performance

How have Spectrum Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$172.63M
Net income
-$155.99M
Gross margin
N/A
Net margin
N/A
The operating income has contracted by 29% YoY
SPPI's net income is down by 16% YoY but it is up by 3% QoQ

Growth

What is Spectrum Pharmaceuticals's growth rate over time

Valuation

What is Spectrum Pharmaceuticals stock price valuation
P/E
N/A
P/B
4.07
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 9% QoQ and by 2.5% YoY
Spectrum Pharmaceuticals's equity has decreased by 20% YoY and by 9% QoQ
SPPI's price to book (P/B) is 9% higher than its 5-year quarterly average of 3.6 and 9% higher than its last 4 quarters average of 3.6

Efficiency

How efficient is Spectrum Pharmaceuticals business performance
SPPI's return on invested capital has dropped by 81% year-on-year and by 6% since the previous quarter
The return on equity has dropped by 75% year-on-year and by 2.5% since the previous quarter
Spectrum Pharmaceuticals's return on assets has shrunk by 58% YoY

Dividends

What is SPPI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SPPI.

Financial health

How did Spectrum Pharmaceuticals financials performed over time
Spectrum Pharmaceuticals's total assets has decreased by 17% YoY and by 9% QoQ
SPPI's total liabilities is down by 10% since the previous quarter and by 9% year-on-year
Spectrum Pharmaceuticals's debt is 100% less than its equity
Spectrum Pharmaceuticals's equity has decreased by 20% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.